Evidence map›Paper›PMID 34063863›Full record

ArticleVaccines2021

COVID-19 Pandemic and Equal Access to Vaccines.

Matteo Bolcato, Daniele Rodriguez, Alessandro Feola, Giulio Di Mizio, Alessandro Bonsignore, Rosagemma Ciliberti, Camilla Tettamanti, Marco Trabucco Aurilio, Anna Aprile

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Review
  16. Access to the COVID-19 Vaccine.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. A Faster, Novel Technique to Detect COVID-19 Neutralizing Antibodies.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matteo BolcatoLegal Medicine, University of Padua, via G. Falloppio 50, 35121 Padua, Italy.ORCID 0000-0002-8784-8463
Daniele RodriguezLegal Medicine, University of Padua, via G. Falloppio 50, 35121 Padua, Italy.
Alessandro FeolaDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", via Luciano Armanni 5, 80138 Naples, Italy.ORCID 0000-0002-9666-2636
Giulio Di MizioForensic Medicine, Department of Law, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0001-7279-3693
Alessandro BonsignoreDepartment of Health Sciences, Section of Legal and Forensic Medicine, University of Genova, 16132 Genova, Italy.ORCID 0000-0001-6616-0347
Rosagemma CilibertiDepartment of Health Sciences, Section of History of Medicine and Bioethics, University of Genova, 16132 Genova, Italy.
Camilla TettamantiDepartment of Health Sciences, Section of Legal and Forensic Medicine, University of Genova, 16132 Genova, Italy.
Marco Trabucco AurilioDepartment of Medicine and Health Sciences "V. Tiberio," University of Molise, 86100 Campobasso, Italy.ORCID 0000-0003-2327-1455
Anna AprileLegal Medicine, University of Padua, via G. Falloppio 50, 35121 Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has evidenced the chronic inequality that exists between populations and communities as regards global healthcare. Vaccination, an appropriate tool for the prevention of infection, should be guaranteed by means of proportionate interventions to defeat such inequality in populations and communities affected by a higher risk of infection. Equitable criteria of justice should be identified and applied with respect to access to vaccination and to the order in which it should be administered. This article analyzes, as regards the worldwide distribution of anti-COVID-19 vaccines, the various ways the principle of equity has been construed and applied or even overlooked. The main obstacle to equal access to vaccines is vaccine nationalism. The perception of equity varies with the differing reference values adopted. Adequate response to needs appears to be the principal rule for achieving the criterion of equity in line with distributive justice. Priorities must be set equitably based on rational parameters in accordance with current needs. The entire process must be governed by transparency, from parameter identification to implementation. The issue of equal access to vaccination affects the entire world population, necessitating specific protective interventions. In light of this, the World Health Organization (WHO) has devised the COVAX plan to ensure that even the poorest nations of the world receive the vaccine; certain initiatives are also supported by the European Union (EU). This pandemic has brought to the fore the need to build a culture of equitable relationships both in each country's own domain and with the rest of the world.

Indexed as

COVAXCOVID-19equitypublic healthvaccination

Identifiers

PMID34063863
PMCPMC8224034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.